Loading...
Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer
Incidence of infusion related reaction (IR) is more common with cetuximab (Cmab) than with panitumumab (Pmab). Although little is known about rechallenge IR with monoclonal antibodies, we experienced a successful rechallenge to Cmab after IR to Pmab. A 67-year-old female patient was scheduled for ch...
Na minha lista:
| Udgivet i: | Int Cancer Conf J |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Singapore
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797389/ https://ncbi.nlm.nih.gov/pubmed/33489709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00455-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|